Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Purchased by Capital Group Investment Management PTE. LTD.

Capital Group Investment Management PTE. LTD. raised its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 2.5% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 13,655 shares of the medical equipment provider’s stock after purchasing an additional 339 shares during the period. Intuitive Surgical comprises 1.4% of Capital Group Investment Management PTE. LTD.’s investment portfolio, making the stock its 18th biggest position. Capital Group Investment Management PTE. LTD.’s holdings in Intuitive Surgical were worth $7,127,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds and other institutional investors have also made changes to their positions in the stock. Norges Bank purchased a new position in shares of Intuitive Surgical in the 4th quarter valued at about $2,401,493,000. Proficio Capital Partners LLC boosted its holdings in Intuitive Surgical by 89,098.8% in the fourth quarter. Proficio Capital Partners LLC now owns 949,967 shares of the medical equipment provider’s stock valued at $495,845,000 after purchasing an additional 948,902 shares in the last quarter. Raymond James Financial Inc. purchased a new position in Intuitive Surgical in the fourth quarter valued at approximately $313,769,000. Wilmington Savings Fund Society FSB raised its holdings in Intuitive Surgical by 15,322.2% during the third quarter. Wilmington Savings Fund Society FSB now owns 555,661 shares of the medical equipment provider’s stock worth $272,980,000 after purchasing an additional 552,058 shares in the last quarter. Finally, Vanguard Group Inc. lifted its position in shares of Intuitive Surgical by 1.1% during the 4th quarter. Vanguard Group Inc. now owns 32,212,196 shares of the medical equipment provider’s stock worth $16,813,478,000 after buying an additional 360,591 shares during the last quarter. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Price Performance

NASDAQ:ISRG opened at $482.74 on Friday. The firm has a market cap of $171.94 billion, a PE ratio of 75.31, a P/E/G ratio of 5.85 and a beta of 1.55. The firm has a 50 day simple moving average of $524.41 and a 200-day simple moving average of $532.04. Intuitive Surgical, Inc. has a 1-year low of $364.17 and a 1-year high of $616.00.

Insider Transactions at Intuitive Surgical

In other news, CFO Jamie Samath sold 94 shares of Intuitive Surgical stock in a transaction dated Wednesday, January 29th. The stock was sold at an average price of $571.11, for a total value of $53,684.34. Following the transaction, the chief financial officer now directly owns 2,630 shares of the company’s stock, valued at $1,502,019.30. The trade was a 3.45 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this link. Also, EVP Myriam Curet sold 408 shares of the stock in a transaction that occurred on Tuesday, February 11th. The stock was sold at an average price of $589.75, for a total transaction of $240,618.00. Following the sale, the executive vice president now directly owns 353 shares of the company’s stock, valued at approximately $208,181.75. This trade represents a 53.61 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 33,754 shares of company stock worth $17,691,621 in the last three months. Company insiders own 0.70% of the company’s stock.

Wall Street Analyst Weigh In

A number of research analysts recently commented on the stock. Leerink Partners increased their target price on shares of Intuitive Surgical from $490.00 to $548.00 in a research report on Monday, January 27th. UBS Group lifted their target price on Intuitive Surgical from $500.00 to $560.00 and gave the stock a “neutral” rating in a research report on Monday, January 27th. Raymond James upped their target price on Intuitive Surgical from $560.00 to $688.00 and gave the company an “outperform” rating in a research report on Friday, January 24th. Robert W. Baird cut their price target on Intuitive Surgical from $707.00 to $600.00 and set an “outperform” rating on the stock in a research report on Tuesday, March 18th. Finally, Jefferies Financial Group increased their price objective on Intuitive Surgical from $475.00 to $575.00 in a report on Monday, January 27th. One analyst has rated the stock with a sell rating, five have assigned a hold rating and fifteen have given a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $611.81.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.